Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/23241Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Papadopoulou, E. | en |
| dc.contributor.author | Davilas, E. | en |
| dc.contributor.author | Sotiriou, V. | en |
| dc.contributor.author | Koliopanos, A. | en |
| dc.contributor.author | Aggelakis, F. | en |
| dc.contributor.author | Dardoufas, K. | en |
| dc.contributor.author | Agnanti, N. J. | en |
| dc.contributor.author | Karydas, I. | en |
| dc.contributor.author | Nasioulas, G. | en |
| dc.date.accessioned | 2015-11-24T19:31:17Z | - |
| dc.date.available | 2015-11-24T19:31:17Z | - |
| dc.identifier.issn | 0965-0407 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/23241 | - |
| dc.rights | Default Licence | - |
| dc.subject | Cell-Free System/*metabolism | en |
| dc.subject | DNA/*blood/genetics | en |
| dc.subject | Genetic Markers/*physiology | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Prostatic Neoplasms/*blood/genetics | en |
| dc.subject | RNA/*blood/genetics | en |
| dc.subject | Statistics, Nonparametric | en |
| dc.title | Cell-free DNA and RNA in plasma as a new molecular marker for prostate cancer | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/15490975 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2004 | - |
| heal.abstract | Extracellular nucleic acids could serve as molecular markers in the early detection of cancer and in the prediction of disease outcome. In this study we examined six molecular markers, such as: variations in the quantity of DNA in plasma, glutathione-S-transferase P1 (GSTP1) gene methylation status in plasma, carcinoembryonic antigen (CEA) and prostate-specific membrane antigen (PSMA) mRNA in peripheral blood mononuclear cells (PBMC), and plasma samples from prostate cancer patients in different stages. The combination of DNA load and GSTP1 promoter methylation status identified 83% (10/12) of the prostate cancer patients before therapy. This study shows that free circulating DNA can be detected in patients with prostate cancer compared with disease-free individuals, and suggests a new, noninvasive approach for early detection of prostate cancer. | en |
| heal.journalName | Oncol Res | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
